Moment-to-moment adjustment of cerebral blood flow (CBF) to neuronal activity via the homeostatic mechanism known as neurovascular coupling (NVC) has an essential role in maintenance of normal brain function. In advanced age cerebromicrovascular endothelial dysfunction impairs NVC responses, which contribute to age-related cognitive decline. Recently, we have shown that pharmacological treatments that atten-uate mitochondrial production of reactive oxygen species (ROS) provide significant neurovascular protection, improving NVC responses in aged mice. Transgenic mice that overexpress human catalase localized to the mitochondria (mCAT) are protected from age-related mitochondrial oxidative stress and exhibit a longevity phenotype associated with resistance to several agerelated pathologies. The present study was designed to test the hypothesis that mitochondria-targeted overexpression of catalase also confers protection against agerelated impairment of NVC responses. To achieve this goal, NVC responses were assessed in aged (24 months old) mCAT mice and compared with those in agematched wild-type mice and young control mice by measuring CBF responses (laser speckle contrast imaging) evoked by contralateral whisker stimulation. We found that mitochondrial overexpression of catalase resulted in improved NVC in aged mice due to preserved NO-mediated (L-NAME inhibitable) component of the response. Thus, our present and previous findings demonstrate that interventions that boost mitochondrial antioxidative defenses confer significant cerebromicrovascular protective effects, which preserve NVC responses in aged mice. Our findings provide additional proof-of-concept for the potential use of mitochondria-targeted antioxidants as therapy for prevention of vascular cognitive impairment associated with aging.
Introduction
Moment-to-moment adjustment of cerebral blood flow (CBF) to neuronal activity via the homeostatic mechanism known as neurovascular coupling (NVC, also known as Bfunctional hyperemia^) has an essential role in maintenance of normal brain function (Tarantini et al. 2017a) . NVC is responsible for increased oxygen and nutrient delivery to the activated neurons, for the effective wash-out of toxic metabolites and for maintenance of an optimal humoral microenvironment within the cerebral tissue. There is an increasing appreciation that vascular contributions to cognitive impairment and dementia (termed BVCID^) play a critical role in older individuals (Tarantini et al. 2016; Carlson et al. 2018; Csipo et al. 2018; Gillon et al. 2018; Ungvari et al. 2018a; Csiszar et al. 2017; Tarantini et al. 2017b; Tucsek et al. 2017; Ungvari et al. 2017; Tarantini et al. 2017c Tarantini et al. , 2018a Tarantini et al. , b, 2019 Toth et al. 2017) . Importantly, NVC responses are impaired both in older adults Zaletel et al. 2005; Topcuoglu et al. 2009; Stefanova et al. 2013; Fabiani et al. 2013) and aged rodents Toth et al. 2014; Park et al. 2007) , which contributes significantly to the progressive age-related decline in cognitive function (Sorond et al. 2011 (Sorond et al. , 2013 . Further support for this concept is provided by experimental studies demonstrating that pharmacologically induced NVC dysfunction in young mice mimics important aspects of age-related cognitive impairment (Tarantini et al. 2015 (Tarantini et al. , 2017b .
Production of vasodilator NO by the microvascular endothelial cells is stimulated during neuronal activation, which critically contributes to functional hyperemia in the healthy young brain (Toth et al. 2015a; Chen et al. 2014) . There is strong evidence that in advanced age, cerebromicrovascular endothelial dysfunction plays a critical role in the genesis of NVC dysfunction Toth et al. 2014) . Recent studies demonstrate that therapeutic interventions, which restore endothelium-dependent, NOmediated vasodilation in aging, have the capacity to rescue NVC responses and thereby improve cognition (Tarantini et al. 2017a Toth et al. 2014 Toth et al. , 2017 . A basic tenet in the field of geroscience is that fundamental cellular and molecular mechanisms of aging underlie all the functional changes in each organ system associated with advanced age and contribute to the pathogenesis of age-related diseases (Kennedy et al. 2014; Sierra and Kohanski 2017; Ashpole et al. 2017; Deepa et al. 2017; Fang et al. 2017; Grant et al. 2017; Podlutsky et al. 2017; Unnikrishnan et al. 2017; Lee et al. 2018; Nacarelli et al. 2018; Reglodi et al. 2018 ). Thus, with respect to age-related cerebrovascular dysfunction, it is predicted that novel treatments that target fundamental cellular and molecular mechanisms of aging could be developed to improve NVC responses for cognitive benefits (Toth et al. 2017) .
The mitochondrial theories of aging predict that increased production of mitochondria-derived ROS (mtROS), consequences of mitochondrial stresses (mitochondrial unfolded protein response, alterations of mitochondrial signals, such as dysregulation of mitochondria-derived peptides, mitochondria-derived damage-associated molecular patterns), and related mitochondrial dysfunction (including impaired mitochondrial energy metabolism, age-related NAD+ depletion) are a critical driving force in the aging process. Multiple lines of evidence, ranging from observations in model organisms (Ng et al. 2014; Katsyuba et al. 2018) to studies on rodent lifespan and health span Dai et al. 2011 Dai et al. , 2014 Siegel et al. 2013; Schriner and Linford 2006; Schriner et al. 2005) , support the validity of these interrelated theories. Recently, we have shown that pharmacological treatments that attenuate mtROS production and/or restore mitochondrial function, including treatment with the mitochondrial-targeted antioxidative peptide SS-31 , the NAD+ precursor nicotinamide mononucleotide (NMN) (which attenuates mitochondrial oxidative stress by improving electron transport chain coupling by activating SIRT1 Kiss et al. 2019; Csiszar et al. 2019) ), and the mitochondria-targeted antioxidant MitoQ , provide significant neurovascular protection, improving NVC responses in aged mice. Importantly, transgenic mice that overexpress human catalase localized to the mitochondria (mCAT) are protected from age-related mitochondrial oxidative stress and mitochondrial dysfunction, which associate with a significant extension of both median and maximum lifespans (by~5 to 5.5 months) (Schriner and Linford 2006; Schriner et al. 2005) . mCAT mice also exhibit resistance to several age-related pathologies, including metabolic syndrome and atherosclerosis, cardiac aging, heart failure, skeletal muscle pathology, sensory defect, neurodegenerative diseases, and cancer (Dai et al. 2009 (Dai et al. , 2017 Ge et al. 2015; Lee et al. 2010; Olsen et al. 2013; Selvaratnam and Robaire 2016; Treuting et al. 2008; Wang et al. 2017) . Despite these advances, the effects of mitochondrial catalase overexpression on cerebral vasculature remain unexplored.
The present study was designed to test the hypothesis that mitochondria-targeted overexpression of catalase can improve NVC responses in aged mice. To achieve this goal, NVC responses were assessed in aged (24 month old) mCAT mice and compared with those in young control and aged control mice by measuring whisker-stimulation-induced increases in CBF (assessed by laser speckle contrast imaging; LSCI).
Methods

Experimental animals
Young (3 month old, n = 6) and aged (24 month old, n = 6) male control C57BL/6 mice and transgenic mice that overexpress human catalase localized to the mitochondria (C57BL/6.mCAT; 24 month old, n = 6) were used. Animals were purchased from the Jackson Laboratories (strain name: B6.Cg-Tg(CAG-OTC/CAT)4033Prab/J; Stock number: 016197). The mCAT mice have a CMV enhancer/chicken beta-actin promoter driving the expression of human catalase gene in mitochondria. Animals were housed under specific pathogen-free barrier conditions in the Rodent Barrier Facility at the University of Oklahoma Health Sciences Center under a controlled photoperiod (12-h light; 12-h dark) with unlimited access to water and were fed a standard AIN-93G diet (ad libitum). All procedures were approved by the Institutional Animal Use and Care Committees of the University of Oklahoma Health Sciences Center.
Assessment of neurovascular coupling responses
Neurovascular coupling responses were assessed as described previously (Tarantini et al. 2017c . In brief, mice in each group were anesthetized with isoflurane (2% induction and 1% maintenance), endotracheally intubated, and ventilated (MousVent G500; Kent Scientific Co, Torrington, CT). A thermostatic heating pad (Kent Scientific Co, Torrington, CT) was used to maintain rectal temperature at 37°C (Toth et al. 2014 ). End-tidal CO 2 was controlled between 3.2 and 3.7% to keep blood gas values within the physiological range, as described (Tarantini et al. 2015; Toth et al. 2015b ). The right femoral artery was cannulated for arterial blood pressure measurement (Living Systems Instrumentations, Burlington, VT) (Toth et al. 2014) . The blood pressure was within the physiological range throughout the experiments (90-110 mmHg). Mice were immobilized and placed on a stereotaxic frame (Leica Microsystems, Buffalo Grove, IL), the scalp and periosteum were pulled aside, and the skull was gently thinned using a dental drill while cooled with dripping buffer. A laser speckle contrast imager (Perimed, Järfälla, Sweden) was placed 10 cm above the thinned skull, and to achieve the highest CBF response, the right whiskers were stimulated for 30 s at 5 Hz from side to side. Differential perfusion maps of the brain surface were captured. Changes in CBF were assessed above the left barrel cortex in six trials in each group, separated by 5-min intervals. To assess the role of NO mediation, CBF responses to whisker stimulation were repeated after administration of the nitric oxide synthase inhibitor N ω -Nitro-L-arginine methyl ester (L-NAME). Changes in CBF were averaged and expressed as percent (%) increase from the baseline value. Experiments lasted 30 min/mouse, which permitted stable physiological parameters to be obtained. In each study, the experimenter was blinded to the genotype of the animals.
Statistical analysis
Data were analyzed by one-way analysis of variance (ANOVA) followed by Tukey's post hoc test. A P value less than 0.05 was considered statistically significant. Data are expressed as mean ± S.E.M.
Results
Mitochondria-targeted overexpression of catalase rescues neurovascular coupling responses in aged mice by restoring NO mediation CBF responses in the whisker barrel cortex elicited by contralateral whisker stimulation were significantly decreased in aged mice compared with young animals indicating impaired NVC in aging (representative laser speckle contrast images and CBF tracings are shown in Fig. 1 a and b , summary data are shown in Fig. 1c ) (Park et al. 2007) . We found that mitochondria-targeted overexpression of catalase significantly increased CBF responses induced by contralateral whisker stimulation in aged mice, restoring NVC to levels observed in young mice (Fig. 1) . In young animals, administration of the NO synthase inhibitor L-NAME significantly decreased NVC responses, eliminating the differences among the age groups. In untreated aged animals, administration of L-NAME was without effect (Fig. 1a-c) . In contrast, in aged mCAT mice, L-NAME significantly decreased CBF responses elicited by whisker stimulation ( Fig. 1a-c ), suggesting that mitochondria-targeted overexpression of catalase restored the NO mediation of neurovascular coupling in aged animals.
Discussion
The key finding of this study is that mCAT mice exhibit an antiaging neurovascular phenotype, which results in preserved NVC responses in advanced aging.
Endothelium-derived NO production contributes significantly to normal NVC responses in young mammals. Several lines of evidence support this view, including the observations that genetic deficiency of eNOS, pharmacological inhibition of NO synthesis, endothelial injury, and endotheliumspecific depletion of critical vasoprotective factors can similarly impair NVC responses Toth et al. 2014 Toth et al. , 2015a Chen et al. 2014) . Strong evidence demonstrates that aging associates with generalized endothelial dysfunction Csipo et al. 2019; Ungvari et al. 2018b ). Extending previous findings in elderly patients and aged laboratory animals, we confirm that aging-induced impairment of cerebromicrovascular endothelial function critically contributes to neurovascular uncoupling in aged mammals (Tarantini et al. 2017a Park et al. 2007) . Here, we demonstrate for the first time that aging-induced decline in NVC is prevented by overexpression of catalase targeted to the mitochondria. These findings extend the results of our earlier investigations, demonstrating that pharmacological treatments, which attenuate mitochondrial oxidative stress, including treatment with SS-31 ), resveratrol (Toth et al. 2014; Ungvari et al. 2009 ), and MitoQ , also exert significant beneficial effects on NVC responses in aged mice. Importantly, we find that both overexpression of catalase targeted to the mitochondria and treatment with mitochondria-targeted antioxidative peptide SS-31 ) rescue endothelial NO mediation of NVC responses in aged animals. Previous studies show that treatment with mitochondria-targeted antioxidants (MitoQ, SS-31) also rescues agonist-induced, endothelial NOmediated vasodilation in peripheral arteries in aged mice Gioscia-Ryan et al. 2014) . MitoQ was also shown to improve endothelial function in peripheral arteries in older adults (Rossman et al. 2018) .
Previous studies suggest that the mechanism(s) by which aging impairs vascular endothelial function involves an increased breakdown of NO by increased levels of superoxide (Toth et al. 2014; Csiszar et al. 2002) (Fig. 2) . Although SS-31 and MitoQ are thought to directly reduce superoxide production, mCAT mice express catalase in the mitochondria, which is expected to primarily attenuate the mitochondrial levels of H 2 O 2 . As H 2 O 2 readily can penetrate the mitochondrial membranes, it is expected that cytosolic levels of H 2 O 2 will be also significantly attenuated. However, decreased Fig. 2 Proposed role for increased mitochondrial oxidative stress in cerebromicrovascular endothelial impairment and neurovascular dysfunction in aging. The scheme depicts that age-related decline in circulating IGF-1 (Csiszar et al. 2008 ), impairment of Nrf2-regulated antioxidant mechanisms Ungvari et al. 2018b; Dai et al. 2012; Bailey-Downs et al. 2012; Fulop et al. 2018; Ungvari et al. 2011a, b) , decline in NAD+ levels and SIRT1 activity and consequential dysregulation of components of the electron transport chain (ETC) , upregulation of NADPH oxidases (NOX) (Park et al. 2007) , and the local renin-angiotensin system (RAS) (Dai et al. 2012 ) act synergistically to promote increased mitochondrial production of reactive oxygen species (mtROS). Mitochondrial oxidative stress promotes mtDNA damage, exacerbating mitochondrial dysfunction, promotes peroxynitrite (ONOO.-) formation reducing bioavailability of NO, promotes NFkB activation (Ungvari et al. 2007) , and induces endothelial senescence. All of these mechanisms contribute to endothelial dysfunction, which impair neurovascular coupling responses compromising cognitive function. The model predicts that diverse interventions that attenuate mitochondrial oxidative stress will confer endothelial protection, improving neurovascular coupling responses, thereby preserving cognitive function in old age. Accordingly, overexpression of catalase targeted to the mitochondria (mCAT), treatment with mitochondria-targeted antioxidants (SS-31), and sirtuin-activating treatments (e.g., the NAD+ booster nicotinamide mononucleotide [NMN]) attenuate mtROS production in endothelial cells, improving cerebromicrovascular endothelial function and rescuing neurovascular coupling responses H 2 O 2 levels and increased bioavailability of NO are likely not causally linked. Because direct scavenging of NO is attributed to increased superoxide levels, it is likely that attenuation of H 2 O 2 confers endothelial protection via indirect effects. For example, attenuation of H 2 O 2 levels likely limits oxidative mtDNA damage as well as oxidative modification of lipids and protein damage, which may contribute to the preservation of a youthful mitochondrial function. These factors likely prevent age-related loss of efficiency in mitochondrial electron transport, which should decrease electron leak thereby attenuating mitochondrial superoxide production. Indirect attenuation of mitochondrial superoxide production is expected to increase NO bioavailability. In addition, there is growing evidence that mitochondriaderived ROS regulate the expression/activity of plasma membrane-associated NADPH oxidases in endothelial cells (Dai et al. 2012) . Accordingly, in the cerebral vasculature of aged mice, increased mtROS is associated with an upregulation of NADPH oxidases (Toth et al. 2014; Park et al. 2007 ), which may be reversed by interventions that attenuate mtROS production Toth et al. 2014 ). Thus, it is possible that mitochondria-targeted overexpression of catalase may also alter the interplay between mitochondrial ROS and NADPH oxidases, disrupting a vicious feed-forward cycle that diminishes NO bioavailability, impairing NVC responses. This possibility should be experimentally tested in future studies. An additional method by which mCAT may exert endothelial protective effects involves preservation of mitochondrial/ cellular energetics.
In conclusion, our present and previous findings demonstrate that interventions that boost mitochondrial a n t i o x i d a t i v e d e f e n s e s c o n f e r s i g n i f i c a n t cerebromicrovascular protective effects, which rescue NVC responses in aged mice (Fig. 2) . Our findings provide additional proof-of-concept for the potential use of mitochondria-targeted antioxidants as therapy for prevention of vascular cognitive impairment associated with aging.
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